DNA X, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:SONM) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -4.51 M-9.61 M-4.88 M-7.03 M-2 M-3.47 M -17.39 M Cash from investing activities -8 00000003.36 M 3.36 M Cash from financing activities 800 K6.38 M4.77 M7.17 M1.17 M0 13.11 M Free cash flow -4.51 M-9.61 M-4.88 M-7.03 M-2 M-3.47 M -17.39 M

News

Sonim Technologies rebrands as DNA X following asset sale to NEXA

Sonim stockholders approve sale of rugged device business to NEXA

Dow Gains Over 100 Points; US Jobless Claims Decline - Citius Pharmaceuticals (NASDAQ:CTXR), Multi Ways Holdings (AMEX:MWG)

Why Vision Marine Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - CEA Industries (NASDAQ:BNC), Aditxt (NASDAQ:ADTX)

Sonim Technologies to vote on $15 million asset sale to NEXA

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.71%

Upcoming Stock Splits This Week (October 27 to October 31) – Stay Invested - TipRanks.com

Sonim Technologies to implement 1-for-18 reverse stock split on October 27

Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Aditxt (NASDAQ:ADTX), Adaptimmune Therapeutics (NASDAQ:ADAP)

Sonim launches ultra-rugged XP3plus 5G flip phone on AT&T

Sonim launches ultra-rugged XP Pro smartphone across Canada

Sonim Technologies grants special director awards and reports annual meeting vote results